compared to the IRI control group. A greater increase in glutathione reductase and glutathione peroxidase was observed in renal cotex of hypoxic preconditioned hBMSC injection than in the IRI control group. These findings further suggest that anti-oxidative responses were elicited by IRI and hBMSC treatment contributed to further anti-inflammatory and anti-oxidative effects after IRI in this study.
INTRODUCTION AND OBJECTIVES:
In vitro 3D organoids provide an alternative model for studying of renal toxicology. However, to obtain human renal tubular epithelial cells for these propose, a kidney biopsy is required, with potential risks and complications due to this invasive procedure. Development of in vitro renal tissue model has been limited due to the challenges of differentiating stem cells into various functional renal cells. Our previous studies have demonstrated that human urine-derived stem cells (USCs) originate from glomerular parietal stem cells, possess self-renewal and multipotent capacity2. The goal of this study is to induce human USCs to differentiate into renal tubule epithelial cells when grown on kidney extracellular matrix (k-ECM) to generate in vitro 3D renal tubular organoids for potential use as biological models for nephrotoxic drug development and for renal repair.
METHODS: USCs obtained from 4 healthy individuals were isolated and expanded in vitro. Normal human renal cells were used as control. Porcine-derived k-ECM hydrogen was produced (k-ECM gel) when mixed with hydraulic acid gel (1:9). To generate the renal tubular organoids, USCs were induced within 1% k-ECM gel for one week, compared to USC aggregates without k-ECM gel. The organoids of USCsþk-ECM gel were cultured in Hanging Drop 96-well plates for 4 days and then transferred to ultra-low attachment plates. To optimize the protocols and measure cell viability, different cell concentrations were assessed by ATPase and LIVE/DEAD Kit. The size of organoids and the renal tubule structures were assessed by histology, immunofluorescence staining and Western blot using renal tubular epithelial cell markers. Renal tubular cell function was measured by ?-Glutamyltransferase (GGT) activity after Ethanol as nephrotoxic agent was added into the culture medium.
RESULTS: 3D organoids (about 350mm at diameter) were generated by 4,000 USCs cultured for 7 days. ATPase and LIVE/DEAD assays showed that majority of USCs (>95%) remained viable up to 4 weeks. H.E. staining demonstrated the renal tubular-like structures formed within the USCsþk-ECM gel, but no within the USC aggregates without k-ECM gel. Induced USCs expressed proximal renal tubule epithelial cells marker (Aquaporin 1, i.e. AQP1) within whole mount staining. In addition, induced USCs expressing GGT was similar to normal renal cells after ethanol treatment.
CONCLUSIONS: Human USCs induced by k-ECM formed renal tubular organoids, which could provide an alternative tool for nephrotoxic drug screening, renal disease research and kidney tissue repair. (CSCs) . However, the underlying molecular mechanism in chemotherapy-induced CSCs enrichment and following chemoresistance and recurrence remains largely unclear.
Source of
METHODS: Gemcitabine and cisplatin (GC) chemoresistant cell lines (T24 GC 3rd and 5637 GC 3rd cells) and the chemo-sensitive UBC cell lines T24 and 5637 were established in vivo for the investigation of acquired resistance mechanisms. The role of miR34a/ GOLPH3 axis in regulating UBC chemoresistance and recurrence was evaluated in cell and animal models. The expression levels of miR34a/ GOLPH3 axis and CSCs markers were assayed in specimens of UBC. The association of GOLPH3 with clinicopathologic features and prognosis was analysed.
RESULTS: RT-PCR and western blotting confirmed that the expression levels of miR34a were decreased and GOLPH3 were increased in GC chemoresistant UBC cell lines. Downregulation of miR34a resulted in the overexpression of GOLPH3, which is a target gene of miR34a confirmed by luciferase experiment. The ectopic expression of miR34a decreased the stem cell properties of chemoresistant UBC cells and re-sensitized these cells to GC treatment in vitro and in vivo. Moreover, miR34a/GOLPH3 axis has obvious clinical relevance with prognosis and recurrence in human UBC patients with standard GC chemotherapy.
CONCLUSIONS: Our results suggest that miR34a/GOLPH3 axis exert key role in CSCs involved UBC drug resistance and recurrence and warrant further development as a promising therapeutic approach in treating drug-resistant UBC. 
MP81-06 THE THERAPEUTIC EFFECT OF HUMAN EMBRYONIC STEM CELL-DERIVED MULTIPOTENT MESENCHYMAL STEM CELLS ON KETAMINE-INDUCED CYSTITIS IN RATS
Jung hyun Shin*, Seoul, Korea, Republic of; Sang Wook Lee, Chunchon, Korea, Republic of; Chae-Min Ryu, Aram Kim, Hwan Yeul Yu, Dong-Myung Shin, Myung-Soo Choo, Seoul, Korea, Republic of INTRODUCTION AND OBJECTIVES: The purpose of this study was to evaluate the therapeutic effect of human embryonic stem cell (hESC)-derived multipotent mesenchymal stem cells (M-MSCs) on ketamine-induced cystitis (KC) in rats.
METHODS: To induce KC, 10-week-old female rats were given 25mg/kg ketamine hydrochloride twice a week for 12 weeks. For the sham group, phosphate buffered saline (PBS) was injected instead of ketamine. One week after final injection of ketamine, the indicated dose (0.25, 0.5, and 1 x 10 6 cells) of M-MSCs (KC þ M-MSC group) or PBS vehicle (KC group) was directly injected into the submucosal layer of the anterior wall or dome of the bladder. One week after M-MSCs injection, e1098 THE JOURNAL OF UROLOGY â Vol. 199, No. 4S, Supplement, Monday, May 21, 2018 the therapeutic outcomes were examined by conscious cystometry, histological analyses, and gene expression analyses. Next, we compared the efficacy of M-MSCs at a low dosage (1 x 10 5 cells) with adult bone-marrow (BM)-derived MSCs.
RESULTS: Rats in the KC group exhibited irregular voiding frequencies and decreased micturition interval (MI) compared with the sham group rats. A transplantation of M-MSCs (0.25, 0.5, and 1 x 10 6 cells; KC þ M-MSC group) significantly increased the MI as a dose dependent manner. Bladder capacity and micturition volume of rats in the KC group decreased significantly compared with those in the sham group. However, these parameters were reversed after transplantation of M-MSCs with every cell dosage. The bladders in the KC group exhibited markedly increased infiltration of Toluidine blue stained mast cells and a higher number of TUNEL stained apoptotic cells, compared to the sham group. The administration of M-MSCs significantly reversed the infiltration of mast cell and apoptosis detected in the KC bladders. Furthermore, M-MSC therapy helped to prevent the bladder tissue fibrosis. The gene expression analyses indicated that several genes related to tissue fibrosis, including TGF-b1 and TGF-b2, were markedly upregulated in the KC bladder. However their expression was significantly suppressed by the administration of M-MSCs. Importantly, MMSCs ameliorated the bladder function of KC rats at a low dose (1 x 10 5 ) of cells for which BM-derived MSCs did not substantially improve aberrant bladder function.
CONCLUSIONS: This study demonstrates for the first time the therapeutic efficacy of hESC-derived M-MSCs on KC in rats. The injection of M-MSCs restores bladder function with superior efficacy compared to BM-derived MSCs by protecting against the abnormal alteration in mast cell infiltration, apoptosis and fibrotic damage. Although BDNF well known to be upregulated during PBO, its role in regeneration is undisputed in the brain and other organs. We hypothesize that regulation of BDNF isoforms and doses is crucial for appropriate regeneration of bladder smooth muscle cell (BSMC).
METHODS: In Sprague-Dawley female rats, 75% of the bladder was removed (STC), while the remainder was closed with 7-0 polyglycolic acid sutures. The STC were compared to shams (n¼3,5 for 1, 7 wks), PBO (n¼5, at 7 wks) and cystotomy controls (n¼4,5 for 1, 7 wks). PBO was performed by tying a 8-0 silk ligature around 0.9 mm rod, which was then removed. Expression levels of BDNF isoforms, calponin and myosin were assayed by QPCR (delta-delta c(t) method) and indirect immunofluorescence. Scratch wounds were performed on monolayers of human BSMC in 12 well plates or chamber slides, utilizing a pipette tip and visualizing migration of cells by live cell microscopy. To test if scratch wounding increased BDNF expression, BSMC undergoing scratch or no wounds were assayed for BDNF isoforms by QPCR. To assess migration, scratch wounded BSMC were randomized to treatment with soluble BDNF receptor (TrkB) or vehicle. Exogenous BDNF was added to BSMC at 2.5, 5 and 10 ng/mL for 24-48 hours, followed by cell counting, immunofluorescence for calponin and phospho-histone3 and western blotting for myosin. RESULTS: Total BDNF was upregulated in STC (3.6-fold vs. sham at 7 weeks, p<0.035) vs PBO (>6-fold at 7 weeks, vs sham). The isoforms of BDNF were differentially regulated during STC compared to PBO, as variant1 was not upregulated in STC bladders, but was increased >370 fold during obstruction. In BSMC, 10 ng/mL BDNF decreased SMC markers calponinþmyosin, whereas at 2.5 ng/mL, it increased phosphoH3 expression, p<0.03. Similar to STC in vivo, scratch wounding increased BDNF expression mildly, at 2-fold, p<0.003. Scratch wound induced migratory behaviour in the BSMC and wound closure in the BSMC monolayers, leading to 70% wound closure at 16 hours. Migration was decreased 15% by soluble TrkB (p<0.02).
CONCLUSIONS: STC and scratch wound induce low level BDNF that increases migration and wound closure and was associated with regeneration. This work supports a role for differential effects of dose and isoforms of BDNF on bladders cells and tissue, which reflects the two-sided associations of BDNF in obstruction vs regeneration. METHODS: Female 10-week-old Sprague-Dawley rats were used for induction of chronic IC model. Chronic IC model was induced with single intravesical instillation of protamine sulfate (0.5ml of PS, 30mg/ml) and lipopolysaccharide (0.5ml of LPS, 2.25mg/ml) for 1 month. 35 rats were divided into five groups (N¼7): sham operation group, chronic IC receiving a single bladder submucosal injection of phosphate-buffered saline (20 mL, IC) or ICþ CHA1 (5 Â 10 5 cells/ 20mL, IV) or ICþ ADMSC (5 Â 10 5 cells/20mL, IV) and intravesical IALURILâ instillation (40mL, 40min). Four weeks after treatment, voiding spot was obtained and analyzed with Image J program. The bladder was harvested for histologic examinations and toluidine blue staining for mast cell. Microarray analysis was done. This study was approved by the Institutional Animal Care and Use Committee at our institution.
RESULTS: Rats in the IC group showed increased voiding frequency (3.5 vs 13.8) and decreased the spot size (3.6 vs 1.2 unit) compared with sham group. Significant improvement of voiding spot pattern in frequency (4.8 and 5.1) and size (3.2 and 3.5 unit) was observed in both CHA1 and ADMSC, however, there was no difference between the two groups and the result was comparable with IALURILâ group. Histological examination revealed a significant decrease in the total number of infiltrated mast cells in CHA1 and ADMSC group compared with the IC rats, and there was no difference between the two stem cell groups. Loss of urothelial integrity and increased neutrophil infiltration in IC group was restored both in CHA1 and ADMSC group. Microarray analysis using DAVID and KEGG pathway for CHA1 cells notes several enriched pathways including, various cellular response, metabolic process, nucleic acid binding and oxidative phosphorylation.
CONCLUSIONS: CHA1 and ADMCS showed comparable therapeutic efficacy in terms of improvement of voiding pattern and histological restoration in chronic IC model. And CHA1 MSC might produce therapeutic effects through multiple mechanisms.
